产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF6176, RRID:AB_2838143.
展开/折叠
DKFZp686M1669; Hexokinase 2; Hexokinase 2 muscle; Hexokinase type II; Hexokinase-2; HK 2; HK II; HK2; HKII; HxK 2; HxK2; HXK2_HUMAN; Muscle form hexokinase;
抗原和靶标
Predominant hexokinase isozyme expressed in insulin-responsive tissues such as skeletal muscle.
- P52789 HXK2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MIASHLLAYFFTELNHDQVQKVDQYLYHMRLSDETLLEISKRFRKEMEKGLGATTHPTAAVKMLPTFVRSTPDGTEHGEFLALDLGGTNFRVLWVKVTDNGLQKVEMENQIYAIPEDIMRGSGTQLFDHIAECLANFMDKLQIKDKKLPLGFTFSFPCHQTKLDESFLVSWTKGFKSSGVEGRDVVALIRKAIQRRGDFDIDIVAVVNDTVGTMMTCGYDDHNCEIGLIVGTGSNACYMEEMRHIDMVEGDEGRMCINMEWGAFGDDGSLNDIRTEFDQEIDMGSLNPGKQLFEKMISGMYMGELVRLILVKMAKEELLFGGKLSPELLNTGRFETKDISDIEGEKDGIRKAREVLMRLGLDPTQEDCVATHRICQIVSTRSASLCAATLAAVLQRIKENKGEERLRSTIGVDGSVYKKHPHFAKRLHKTVRRLVPGCDVRFLRSEDGSGKGAAMVTAVAYRLADQHRARQKTLEHLQLSHDQLLEVKRRMKVEMERGLSKETHASAPVKMLPTYVCATPDGTEKGDFLALDLGGTNFRVLLVRVRNGKWGGVEMHNKIYAIPQEVMHGTGDELFDHIVQCIADFLEYMGMKGVSLPLGFTFSFPCQQNSLDESILLKWTKGFKASGCEGEDVVTLLKEAIHRREEFDLDVVAVVNDTVGTMMTCGFEDPHCEVGLIVGTGSNACYMEEMRNVELVEGEEGRMCVNMEWGAFGDNGCLDDFRTEFDVAVDELSLNPGKQRFEKMISGMYLGEIVRNILIDFTKRGLLFRGRISERLKTRGIFETKFLSQIESDCLALLQVRAILQHLGLESTCDDSIIVKEVCTVVARRAAQLCGAGMAAVVDRIRENRGLDALKVTVGVDGTLYKLHPHFAKVMHETVKDLAPKCDVSFLQSEDGSGKGAALITAVACRIREAGQR
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - P52789 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
Y9 | Phosphorylation | Uniprot | |
K41 | Ubiquitination | Uniprot | |
K49 | Ubiquitination | Uniprot | |
K62 | Ubiquitination | Uniprot | |
K104 | Ubiquitination | Uniprot | |
Y112 | Phosphorylation | Uniprot | |
K147 | Ubiquitination | Uniprot | |
T153 | Phosphorylation | Uniprot | |
K173 | Ubiquitination | Uniprot | |
K176 | Ubiquitination | Uniprot | |
Y238 | Phosphorylation | Uniprot | |
K290 | Ubiquitination | Uniprot | |
Y301 | Phosphorylation | Uniprot | |
K315 | Ubiquitination | Uniprot | |
K323 | Ubiquitination | Uniprot | |
T331 | Phosphorylation | Uniprot | |
K337 | Ubiquitination | Uniprot | |
S340 | Phosphorylation | Uniprot | |
K346 | Ubiquitination | Uniprot | |
S384 | Phosphorylation | Uniprot | |
K401 | Ubiquitination | Uniprot | |
S415 | Phosphorylation | Uniprot | |
K418 | Ubiquitination | Uniprot | |
S445 | Phosphorylation | Uniprot | |
S449 | Phosphorylation | Uniprot | |
K451 | Ubiquitination | Uniprot | |
T457 | Phosphorylation | Uniprot | |
Y461 | Phosphorylation | Uniprot | |
K472 | Ubiquitination | Uniprot | |
T473 | Phosphorylation | Uniprot | |
K488 | Ubiquitination | Uniprot | |
K492 | Ubiquitination | Uniprot | |
K501 | Ubiquitination | Uniprot | |
S506 | Phosphorylation | Uniprot | |
K510 | Ubiquitination | Uniprot | |
T514 | Phosphorylation | Uniprot | |
K525 | Ubiquitination | Uniprot | |
K624 | Ubiquitination | Uniprot | |
K638 | Ubiquitination | Uniprot | |
Y686 | Phosphorylation | Uniprot | |
K738 | Ubiquitination | Uniprot | |
K743 | Ubiquitination | Uniprot | |
S746 | Phosphorylation | Uniprot | |
Y749 | Phosphorylation | Uniprot | |
T762 | Phosphorylation | Uniprot | |
K763 | Ubiquitination | Uniprot | |
K866 | Ubiquitination | Uniprot | |
K873 | Ubiquitination | Uniprot | |
K885 | Ubiquitination | Uniprot | |
S897 | Phosphorylation | Uniprot | |
K899 | Ubiquitination | Uniprot | |
T905 | Phosphorylation | Uniprot |
研究背景
Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate. Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis.
Mitochondrion outer membrane>Peripheral membrane protein. Cytoplasm>Cytosol.
Note: The mitochondrial-binding peptide (MBP) region promotes association with the mitochondrial outer membrane (PubMed:29298880). The interaction with the mitochondrial outer membrane via the mitochondrial-binding peptide (MBP) region promotes higher stability of the protein (PubMed:29298880). Release from the mitochondrial outer membrane into the cytosol induces permeability transition pore (PTP) opening and apoptosis (PubMed:18350175).
Predominant hexokinase isozyme expressed in insulin-responsive tissues such as skeletal muscle.
Monomer (By similarity). Interacts with TIGAR; the interaction increases hexokinase activity in a hypoxia- and HIF1A-dependent manner.
The N- and C-terminal halves of the protein contain a hexokinase domain (PubMed:29298880). In contrast to hexokinase-1 and -3 (HK1 and HK3, respectively), both hexokinase domains display catalytic activity (PubMed:29298880). The region connecting the two hexokinase domains is required for the catalytic activity of the N-terminal hexokinase domain (PubMed:29298880). The N-terminal half regulates stability of the whole enzyme (PubMed:29298880).
Belongs to the hexokinase family.
研究领域
· Environmental Information Processing > Signal transduction > HIF-1 signaling pathway. (View pathway)
· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.
· Human Diseases > Cancers: Overview > Central carbon metabolism in cancer. (View pathway)
· Metabolism > Carbohydrate metabolism > Glycolysis / Gluconeogenesis.
· Metabolism > Carbohydrate metabolism > Fructose and mannose metabolism.
· Metabolism > Carbohydrate metabolism > Galactose metabolism.
· Metabolism > Carbohydrate metabolism > Starch and sucrose metabolism.
· Metabolism > Carbohydrate metabolism > Amino sugar and nucleotide sugar metabolism.
· Metabolism > Biosynthesis of other secondary metabolites > Neomycin, kanamycin and gentamicin biosynthesis.
· Metabolism > Global and overview maps > Metabolic pathways.
· Metabolism > Global and overview maps > Carbon metabolism.
· Organismal Systems > Endocrine system > Insulin signaling pathway. (View pathway)
· Organismal Systems > Digestive system > Carbohydrate digestion and absorption.
文献引用
Application: WB Species: human Sample: MIA PaCa-2 cells
Application: WB Species: Human Sample: SHSY-5Y cells
Application: WB Species: Human Sample: MCF-7 cells
Application: WB Species: Mice Sample: GC cells
Application: WB Species: Mouse Sample: VFL epithelial cells
Application: IF/ICC Species: Mouse Sample: VFL epithelial cells
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.